跳至主要内容
临床试验/NCT01150526
NCT01150526已完成1 期

Efficacy of a New Delivery System for Beta-hydroxy-beta-methylbutyrate

Metabolic Technologies Inc.2 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2010年10月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
41
试验地点
2
主要终点
Decrease in muscle damage and inflammation

研究概览

简要总结

The proposed study will test efficacy of HMB in free acid gel to decrease muscle damage, diminish inflammatory response, and improve muscle strength recovery following an acute exercise stress. HMB in a free acid gel or in CaHMB capsule form will be administered as either a single dose before a bout of acute exercise or in multiple doses (one before and three daily doses for the 4 days following the acute exercise). We hypothesize that HMB in free acid gel will result in less muscle damage, diminished inflammatory response, and improved muscle strength recovery than either a placebo or CaHMB treatment following a bout of acute eccentric exercise. Our endpoints will include measurements of: (1) markers for muscle damage (CPK and LDH); (2) indicators of inflammation (CRP, TNF-α, IL-6, IL-1ra and IL-18); and (3) muscle strength recovery and soreness.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Must live within 50 miles of Ames, Iowa
  • Free of cardiac, liver, pulmonary, and kidney disease
  • Free of chronic inflammatory disease including rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, and psoriasis
  • Free diabetes mellitus
  • Not classified as morbidly obese (BMI must be less than 40)
  • Free of cardiac, liver, pulmonary, and kidney disease
  • No other serious medical illness
  • Normal menstrual cycle and not pregnant or lactating
  • Able to consume supplements and perform required exercise testing

排除标准

  • Live more than 50 miles from Ames, Iowa
  • Presence of cardiac, liver, pulmonary, and kidney disease
  • Presence of chronic inflammatory disease including rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, and psoriasis
  • Diabetes mellitus
  • Classified as morbidly obese (BMI is greater than 40)
  • No other serious medical illness
  • Abnormal menstrual cycle, pregnant or lactating
  • Not able to consume supplements and perform required exercise testing

结局指标

主要结局

Decrease in muscle damage and inflammation

时间窗: 4 days post eccentric exercise bout

Serum analysis for markers of muscle damage (CPK) and inflammation (IL-6, IL-18, IL1ra, TNF-a, CRP) will be measured at 24, 48, 72, and 96 h post exercise bout

次要结局

  • Improvement in strength recovery and decrease in soreness(4 days post eccentric exercise bout)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验